Trending

hepatology

Alnylam hopes for 2018 filing for RNAi liver disease drug

Alnylam hopes for 2018 filing for RNAi liver disease drug

Alnylam is hoping to file a second RNA interference (RNAi) drug with the FDA by the end of 2018

X

Alnylam hopes for 2018 filing for RNAi liver disease drug

https://pharmaphorum.com/news/alnylam-hopes-2018-filing-rnai-liver-disease-drug/

Novo Nordisk board member quits over NASH conflict of interest

Novo Nordisk board member quits over NASH conflict of interest

Mary Szela has quit to avoid a conflict of interest.

X

Novo Nordisk board member quits over NASH conflict of interest

https://pharmaphorum.com/news/novo-nordisk-board-member-quits-nash/

Can Gilead find another Pharmasset in 2017?

Can Gilead find another Pharmasset in 2017?

Company needs to make acquisition to grow, admits CEO.

X

Can Gilead find another Pharmasset in 2017?

https://pharmaphorum.com/news/can-gilead-find-another-pharmasset-2017/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com